Belite Bio (BLTE) operating margin

There is no operating margin history on record here for Belite Bio (BLTE). Figures as of 17 Nov 2026, 22:24 UTC, from the company's filings with the SEC and Yahoo Finance.

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Not enough data

A history of operating margin needs at least 3 fiscal years; none is on record here for Belite Bio. Nothing is estimated to fill the gap.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of Belite Bio and comparable companies
CompanyOperating marginFiscal year
RadNet RDNT4.1%2025
Ligand Pharmaceuticals LGND17.6%2025
Scholar Rock Holding SRRK-404.8%2022
Teleflex TFX12.8%2025
Mirum Pharmaceuticals MIRM-4.2%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BLTE

Belite Bio, figure by figure

Belite Bio (BLTE) overview: price, valuation and scorecardAll health care companies by market value

Belite Bio operating margin: questions and answers

How is Belite Bio's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Belite Bio (BLTE) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/BLTE/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.